Effects of continuous positive airway pressure on cardiac events and metabolic components in patients with moderate to severe obstructive sleep apnea and coronary artery disease: a meta-analysis
- PMID: 37497624
- PMCID: PMC10692926
- DOI: 10.5664/jcsm.10740
Effects of continuous positive airway pressure on cardiac events and metabolic components in patients with moderate to severe obstructive sleep apnea and coronary artery disease: a meta-analysis
Abstract
Study objectives: This meta-analysis aimed to systematically assess the effects of continuous positive airway pressure (CPAP) in secondary prevention of major cardiovascular events (MACEs) in patients with moderate-to-severe obstructive sleep apnea and coronary artery disease.
Methods: PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov were searched for observational studies and randomized controlled trials that compared CPAP with usual care in patients with moderate-to-severe obstructive sleep apnea with coronary artery disease. The primary outcomes were MACEs, all-cause death, acute coronary syndrome, rehospitalization for heart failure, repeat revascularization, and arrhythmia.
Results: A total of 11 studies (5 randomized controlled trials and 6 observational studies) with 5,410 patients reported outcomes of MACEs. Treatment with CPAP was associated with a modest risk reduction in MACEs (risk ratio [RR] 0.87, 95% confidence interval [CI] 0.78 to 0.98; P = .02). Similarly, CPAP significantly reduced the risk of all-cause and cardiovascular death by 23% (RR 0.77, 95% CI 0.60 to 0.99; P = .04; I2 = 0%). Subgroup analysis revealed that CPAP adherence time ≥ 4 hours/night had a greater benefit on MACEs by 42% (RR 0.58, 95% CI 0.42 to 0.79; P < .001; I2 = 0%) and repeat revascularization by 44% (RR 0.56, 95% CI 0.34 to 0.92; P = .02; I2 = 0%). Also, CPAP had a positive effect on systolic and diastolic blood pressure.
Conclusions: CPAP therapy might prevent subsequent MACEs and all-cause death among patients with moderate to severe obstructive sleep apnea and concomitant coronary artery disease. CPAP use exceeding 4 hours/night may add more benefits on MACEs, repeat revascularization, and blood pressure.
Clinical trial registration: Registry: PROSPERO database; Name: Effects of Continuous Positive Airway Pressure on Cardiovascular Events and Metabolic Components in Patients with Obstructive Sleep Apnea and Coronary Artery Disease; URL: https://www.crd.york.ac.uk/prospero/display_record.php?ID= CRD42020213546; Identifier: CRD42020213546.
Citation: Yang D, Li L, Dong J, Yang W, Liu Z. Effects of continuous positive airway pressure on cardiac events and metabolic components in patients with moderate to severe obstructive sleep apnea and coronary artery disease: a meta-analysis. J Clin Sleep Med. 2023;19(12):2015-2025.
Keywords: continuous positive airway pressure; coronary artery disease; meta-analysis; obstructive sleep apnea.
© 2023 American Academy of Sleep Medicine.
Conflict of interest statement
All authors have seen and approved this manuscript. The authors report no conflicts of interest.
Figures






Similar articles
-
Nocturnal blood pressure and nocturnal blood pressure fluctuations: the effect of short-term CPAP therapy and their association with the severity of obstructive sleep apnea.J Clin Sleep Med. 2022 Feb 1;18(2):361-371. doi: 10.5664/jcsm.9564. J Clin Sleep Med. 2022. PMID: 34314347 Free PMC article. Clinical Trial.
-
Cardiovascular and metabolic effects of a mandibular advancement device and continuous positive airway pressure in moderate obstructive sleep apnea: a randomized controlled trial.J Clin Sleep Med. 2022 Jun 1;18(6):1547-1555. doi: 10.5664/jcsm.9908. J Clin Sleep Med. 2022. PMID: 35088708 Free PMC article. Clinical Trial.
-
CPAP increases physical activity in obstructive sleep apnea with cardiovascular disease.J Clin Sleep Med. 2021 Feb 1;17(2):141-148. doi: 10.5664/jcsm.8792. J Clin Sleep Med. 2021. PMID: 32951632 Free PMC article. Clinical Trial.
-
Efficacy of continuous positive airway pressure (CPAP) in the prevention of cardiovascular events in patients with obstructive sleep apnea: Systematic review and meta-analysis.Sleep Med Rev. 2020 Aug;52:101312. doi: 10.1016/j.smrv.2020.101312. Epub 2020 Mar 14. Sleep Med Rev. 2020. PMID: 32248026
-
The Effects of Continuous Positive Airway Pressure Therapy for Secondary Cardiovascular Prevention in Patients with Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis.Rev Cardiovasc Med. 2022 May 27;23(6):195. doi: 10.31083/j.rcm2306195. eCollection 2022 Jun. Rev Cardiovasc Med. 2022. PMID: 39077164 Free PMC article.
Cited by
-
Hypoxia-Induced Insulin Resistance Mediates the Elevated Cardiovascular Risk in Patients with Obstructive Sleep Apnea: A Comprehensive Review.Rev Cardiovasc Med. 2024 Jun 25;25(6):231. doi: 10.31083/j.rcm2506231. eCollection 2024 Jun. Rev Cardiovasc Med. 2024. PMID: 39076340 Free PMC article. Review.
-
Long-Term Management of Sleep Apnea-Hypopnea Syndrome: Efficacy and Challenges of Continuous Positive Airway Pressure Therapy-A Narrative Review.Med Sci (Basel). 2024 Dec 30;13(1):4. doi: 10.3390/medsci13010004. Med Sci (Basel). 2024. PMID: 39846699 Free PMC article. Review.
-
Safety and efficacy of glucagon-like peptide-1 receptor agonists in patients with obstructive sleep apnea: a systematic review and meta-analysis of randomized controlled trials.Eur Clin Respir J. 2025 Mar 24;12(1):2484048. doi: 10.1080/20018525.2025.2484048. eCollection 2025. Eur Clin Respir J. 2025. PMID: 40144943 Free PMC article. Review.
-
Prognostic implications of obstructive sleep apnea in patients with acute coronary syndrome stratified by homocysteine level: a prospective cohort study.Respir Res. 2023 Dec 14;24(1):313. doi: 10.1186/s12931-023-02627-8. Respir Res. 2023. PMID: 38098080 Free PMC article.
-
Racial Disparity in Obstructive Sleep Apnea Care and its Impact on Cardiovascular Health.Curr Sleep Med Rep. 2024 Dec;10(4):414-418. doi: 10.1007/s40675-024-00308-6. Epub 2024 Jun 24. Curr Sleep Med Rep. 2024. PMID: 39463890 Free PMC article.
References
-
- Ooi EL , Rajendran S . Obstructive sleep apnea in coronary artery disease . Curr Probl Cardiol. 2023. ; 48 ( 8 ): 101178 . - PubMed
-
- Lee CH , Sethi R , Li R , et al. . Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention . Circulation. 2016. ; 133 ( 21 ): 2008 – 2017 . - PubMed
-
- Jonas DE , Amick HR , Feltner C , et al. . Screening for obstructive sleep apnea in adults: evidence report and systematic review for the US Preventive Services Task Force . JAMA. 2017. ; 317 ( 4 ): 415 – 433 . - PubMed
-
- Fu Y , Xia Y , Yi H , Xu H , Guan J , Yin S . Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment . Sleep Breath. 2017. ; 21 ( 1 ): 181 – 189 . - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical